14.00 - 14.15
Opening and welcome
14.15 - 15.35
SESSION 1: PNH overview
14.15 - 14.30
Natural history of PNH & Patophysiology
14.30 - 14.45
The fundamentals of IVH, EVH & BTH, including pharmacokinetic & pharmacodynamic BTH
14.45 - 15.00
Thrombosis management in PNH
15.00 - 15.15
PNH & aplastic anaemia: an unmet need
15.15 - 15.35
Roundtable discussion
15.35 - 15.50
Coffee break
15.50 - 17.10
SESSION 2: C5 inhibition
15.50 - 16.05
C5 inhibition history, clinical trials on eculizumab and ravulizumab & real world evidence
16.05 - 16.15
Case report: Challenging patient treated with ravulizumab
16.20 - 16.35
Battling with PNH from physician’s perspective
16.40 - 16.55
Crovalimab clinical trials data
16.55 - 17.05
Case report: Challenging patient treated with crovalimab
17.10 - 17.30
Coffee break
17.30 - 18.40
SESSION 3: PNH worldwide & varia
17.30 - 17.40
PNH in US & Canada
17.40 - 17.50
PNH in Western Europe
17.50 - 18.00
PNH in Central-Eastern Europe
18.00 - 18.10
Is there a place for alloHSCT in PNH?
18.10 - 18.35
PNH in Ukraine & discussion
18.35 - 18.40
Day 1 wrap-up